Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii

NCT04053114 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT04053114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04053114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Withdrawn
Start date
January 1, 2019
Completion date
December 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer